EFFICACY AND SAFETY OF ANTIOXIDANT SUPPLEMENTATION IN WOMEN WITH ENDOMETRIOSIS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

In: International Journal of Innovative Technologies in Social Science · 2026 · vol. 1(4(52)) · doi:10.31435/ijitss.4(52).2026.6772 · W7233551375
OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-11-20 ⓘ

This systematic review of 26 randomized controlled trials finds that antioxidant supplementation modulates oxidative and inflammatory markers in endometriosis, though these biochemical improvements do not consistently translate into significant clinical benefits for pain, quality of life, or pregnancy rates.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-11-19 · read from full text ⓘ

This systematic review of 26 randomized controlled trials evaluated the efficacy and safety of antioxidant supplementation in women with confirmed endometriosis. The analysis found that various antioxidants significantly attenuated oxidative, inflammatory, and angiogenic biomarkers, while vitamins C, E, nanocurcumin, selenium, and vitamin D reduced pelvic pain compared to controls. Despite these biochemical improvements and some enhancements in assisted reproductive technology outcomes, there was no consistent improvement in quality of life or clinical pregnancy rates, leading the authors to classify antioxidants as investigational adjunctive options rather than routine treatments due to study heterogeneity. This paper is centrally about endometriosis — specifically investigating the role of oxidative stress modulation through antioxidant therapy for managing disease symptoms and biological markers.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis affects ~10% of reproductive-age women, causing pain and infertility. Limitations of conventional therapies have driven interest in targeting oxidative stress, though clinical evidence on antioxidant efficacy and safety remains inconsistent. Aim: To evaluate the efficacy, safety, and biomarker impact of antioxidant supplementation in women with endometriosis based on randomized controlled trials (RCTs). Materials and Methods: Following PRISMA guidelines, a systematic PubMed search identified 119 unique records, screened via Rayyan based on PICOS criteria. Eligible studies were RCTs evaluating antioxidant supplementation versus control in adult women with confirmed endometriosis. Ultimately, 26 RCTs met all inclusion criteria. Results: Selected antioxidants significantly attenuated oxidative and inflammatory markers (e.g., reduced hs-CRP with vitamin D; lower IL-1$\beta$, TNF-α, and MDA with astaxanthin/nanocurcumin; suppressed MMP-2/9 and VEGF with resveratrol). Clinically, vitamins C/E, nanocurcumin, selenium, and vitamin D reduced pelvic pain, whereas melatonin, fish oil, and resveratrol showed mixed or no benefit. Quality of life (EHP-30) did not improve vs. placebo, though adjunctive curcumin enhanced generic quality of life and sexual function. Astaxanthin and nanocurcumin increased mature oocyte yield and embryo quality during ART, but without significant improvements in clinical pregnancy rates. Conclusions: Antioxidants effectively modulate oxidative, inflammatory, and angiogenic pathways in endometriosis. However, biochemical improvements do not consistently translate into clinical benefits regarding pain, quality of life, or pregnancy rates. Due to high study heterogeneity and inconsistent safety data, antioxidants should be considered investigational adjunctive options rather than routine treatment.
Full text 13,614 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Background

Endometriosis affects ~10% of reproductive-age women, causing pain and infertility. Limitations of conventional therapies have driven interest in targeting oxidative stress, though clinical evidence on antioxidant efficacy and safety remains inconsistent. Aim: To evaluate the efficacy, safety, and biomarker impact of antioxidant supplementation in women with endometriosis based on randomized controlled trials (RCTs).

Materials and methods

Following PRISMA guidelines, a systematic PubMed search identified 119 unique records, screened via Rayyan based on PICOS criteria. Eligible studies were RCTs evaluating antioxidant supplementation versus control in adult women with confirmed endometriosis. Ultimately, 26 RCTs met all inclusion criteria.

Results

Selected antioxidants significantly attenuated oxidative and inflammatory markers (e.g., reduced hs-CRP with vitamin D; lower IL-1$\beta$, TNF-α, and MDA with astaxanthin/nanocurcumin; suppressed MMP-2/9 and VEGF with resveratrol). Clinically, vitamins C/E, nanocurcumin, selenium, and vitamin D reduced pelvic pain, whereas melatonin, fish oil, and resveratrol showed mixed or no benefit. Quality of life (EHP-30) did not improve vs. placebo, though adjunctive curcumin enhanced generic quality of life and sexual function. Astaxanthin and nanocurcumin increased mature oocyte yield and embryo quality during ART, but without significant improvements in clinical pregnancy rates.

Conclusions

Antioxidants effectively modulate oxidative, inflammatory, and angiogenic pathways in endometriosis. However, biochemical improvements do not consistently translate into clinical benefits regarding pain, quality of life, or pregnancy rates. Due to high study heterogeneity and inconsistent safety data, antioxidants should be considered investigational adjunctive options rather than routine treatment.

References

Becker CM, Bokor A, Heikinheimo O, Horne A, Jansen F, Kiesel L, King K, Kvaskoff M, Nap A, Petersen K, Saridogan E, Tomassetti C, van Hanegem N, Vulliemoz N, Vermeulen N; ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open. 2022 Feb 26;2022(2):hoac009. https://doi.org/10.1093/hropen/hoac009 PMID: 35350465; PMCID: PMC8951218. Van Langendonckt A, Casanas-Roux F, Donnez J. Oxidative stress and peritoneal endometriosis. Fertil Steril. 2002 May;77(5):861-70. https://doi.org/10.1016/s0015-0282(02)02959-x PMID: 12009336. Polak G, Wertel I, Barczyński B, Kwaśniewski W, Bednarek W, Kotarski J. Increased levels of oxidative stress markers in the peritoneal fluid of women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):187-90. https://doi.org/10.1016/j.ejogrb.2012.12.043 Epub 2013 Jan 23. PMID: 23351670. Wyatt J, Fernando SM, Powell SG, Hill CJ, Arshad I, Probert C, Ahmed S, Hapangama DK. The role of iron in the pathogenesis of endometriosis: a systematic review. Hum Reprod Open. 2023 Jul 27;2023(3):hoad033. https://doi.org/10.1093/hropen/hoad033 PMID: 37638130; PMCID: PMC10457727.. Ni C, Li D. Ferroptosis and oxidative stress in endometriosis: A systematic review of the literature. Medicine (Baltimore). 2024 Mar 15;103(11):e37421. https://doi.org/10.1097/MD.0000000000037421 PMID: 38489713; PMCID: PMC10939684. Zhong Y, Qiao X, Huang X, Li Y, Wang R, Liang J, Liu T, Bo W, Lai H, Huang W. The effects of antioxidant supplementation on pain, oxidative stress markers, and clinical pregnancy rate in women with endometriosis: a systematic review and meta-analysis of randomized controlled trials. Front Med (Lausanne). 2025 Oct 29;12:1694281. https://doi.org/10.3389/fmed.2025.1694281 PMID: 41234925; PMCID: PMC12605171.. Esmaeilzadeh S, Sadrzadeh A, Moher D, Sepidarkish M, Alamolhoda SH, Mirabi P. Efficacy of antioxidant supplementation in alleviating endometriosis-related pain: insights from a systematic review and meta-analysis of RCTs. Reprod Biol Endocrinol. 2025 Dec 30;23(1):164. https://doi.org/10.1186/s12958-025-01485-x PMID: 41462252; PMCID: PMC12751427. Amini L, Chekini R, Nateghi MR, Haghani H, Jamialahmadi T, Sathyapalan T, Sahebkar A. The Effect of Combined Vitamin C and Vitamin E Supplementation on Oxidative Stress Markers in Women with Endometriosis: A Randomized, Triple-Blind Placebo-Controlled Clinical Trial. Pain Res Manag. 2021 May 26;2021:5529741. https://doi.org/10.1155/2021/5529741 PMID: 34122682; PMCID: PMC8172324. Mehdizadehkashi A, Rokhgireh S, Tahermanesh K, Eslahi N, Minaeian S, Samimi M. The effect of vitamin D supplementation on clinical symptoms and metabolic profiles in patients with endometriosis. Gynecol Endocrinol. 2021 Jul;37(7):640-645. https://doi.org/10.1080/09513590.2021.1878138 Epub 2021 Jan 29. PMID: 33508990. Nodler JL, DiVasta AD, Vitonis AF, Karevicius S, Malsch M, Sarda V, Fadayomi A, Harris HR, Missmer SA. Supplementation with vitamin D or ω-3 fatty acids in adolescent girls and young women with endometriosis (SAGE): a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2020 Jul 1;112(1):229-236. https://doi.org/10.1093/ajcn/nqaa096 PMID: 32453393; PMCID: PMC7326593. Rostami S, Alyasin A, Saedi M, Nekoonam S, Khodarahmian M, Moeini A, Amidi F. Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, triple-blind placebo-controlled clinical trial. Front Endocrinol (Lausanne). 2023 Mar 20;14:1144323. https://doi.org/10.3389/fendo.2023.1144323 PMID: 37020589; PMCID: PMC10067663. Sargazi-Taghazi M, Ghaznavi H, Sheervalilou R, Razavi M, Sepidarkish M. Add-on effect of curcumin to dienogest in patients with endometriosis: a randomized, double-blind, controlled trial. Phytomedicine. 2025 Jun;141:156715. https://doi.org/10.1016/j.phymed.2025.156715 Epub 2025 Apr 1. PMID: 40220411. Esmaeilzadeh S, Habibolahi F, Moher D, Basirat Z, Gholinia H, Golsorkhtabaramiri M, Mirabi P. Melatonin and sleep parameters in infertile women with endometriosis: first results from the triple-blind randomized controlled trial of administration of melatonin in chronic pelvic pain and sleep disturbance. PLoS One. 2025 Apr 16;20(4):e0321635. https://doi.org/10.1371/journal.pone.0321635 PMID: 40238733; PMCID: PMC12002473. Santanam N, Kavtaradze N, Murphy A, Dominguez C, Parthasarathy S. Antioxidant supplementation reduces endometriosis-related pelvic pain in humans. Transl Res. 2013 Mar;161(3):189-95. https://doi.org/10.1016/j.trsl.2012.05.001 Epub 2012 May 31. PMID: 22728166; PMCID: PMC3484190. Söderman L, Böttiger Y, Edlund M, Järnbert-Pettersson H, Marions L. Adjuvant use of melatonin for pain management in endometriosis-associated pelvic pain-A randomized double-blinded, placebo-controlled trial. PLoS One. 2023 Jun 2;18(6):e0286182. https://doi.org/10.1371/journal.pone.0286182 PMID: 37267394; PMCID: PMC10237656. Jannatifar R, Asa E, Cheraghi E, Verdi A. Nanomicelle curcumin improves oxidative stress, inflammatory markers, and assisted reproductive techniques outcomes in endometriosis cases: a randomized clinical trial. Naunyn Schmiedebergs Arch Pharmacol.2025 Sep;398(9):11933-11941. https://doi.org/10.1007/s00210-025-03958-7 Epub 2025 Mar 15. PMID: 40088332. Gudarzi R, Shabani F, Mohammad-Alizadeh-Charandabi S, Naghshineh E, Shaseb E, Mirghafourvand M. Effect of curcumin on painful symptoms of endometriosis: A triple-blind randomized controlled trial. Phytother Res. 2024 Jan;38(1):147-155. https://doi.org/10.1002/ptr.8030 Epub 2023 Oct 11. PMID: 37818734. Almassinokiani F, Khodaverdi S, Solaymani-Dodaran M, Akbari P, Pazouki A. Effects of Vitamin D on Endometriosis-Related Pain: A Double-Blind Clinical Trial. Med Sci Monit. 2016 Dec 17;22:4960-4966. https://doi.org/10.12659/msm.901838 PMID: 27986972; PMCID: PMC5189720. Teihoomaneshfard F, Hajizadeh K, Nasirkandy MP, Shahnazi M, Farshbaf-Khalili A. Efficacy of Organic Selenium Supplementation on Endometrioma Regression and Pain in Women With Endometriosis: A Triple-Blind Randomized Controlled Clinical Trial. Biol Trace Elem Res. 2026 Apr;204(4):2542-2551. https://doi.org/10.1007/s12011-025-04837-1 Epub 2025 Oct 10. PMID: 41073678. Asgari Z, Moini A, Montazeri A, Tavoli Z, Hosseini L, Hosseini R, Tehranian A, Karimi R. Comparing the effect of adjunctive N-acetylcysteine plus low dose contraceptive with low dose contraceptive alone on recurrence of ovarian endometrioma and chronic pelvic pain after conservative laparoscopic surgery: a randomised clinical trial study. J Obstet Gynaecol. 2022 Jul;42(5):1493-1497. https://doi.org/10.1080/01443615.2021.2006165 Epub 2022 Jan 7. PMID: 34994286. Bogusz A, Szewczyk K, Włodarek D, Górnicka M. Effect of Fish-Derived Lipids on Inflammation Status and Health-Related Quality of Life in Women with Endometriosis. Nutrients. 2026 Jul 5;18(13):2184. https://doi.org/10.3390/nu18132184 PMID: 42451184; PMCID: PMC13364014. Pazhohan A, Danaei-Mehrabad S, Mohamad-Rezaeii Z, Amidi F, Khodarahmian M, Shabani Nashtaei M, Sobhani A, Farajzadeh MA. The modulating effects of vitamin D on the activity of β-catenin in the endometrium of women with endometriosis: a randomized exploratory trial. Gynecol Endocrinol. 2021 Mar;37(3):278-282. https://doi.org/10.1080/09513590.2020.1858780 Epub 2020 Dec 11. PMID: 33305626. Kodarahmian M, Amidi F, Moini A, Kashani L, Shabani Nashtaei M, Pazhohan A, Bahramrezai M, Berenjian S, Sobhani A. The modulating effects of Resveratrol on the expression of MMP-2 and MMP-9 in endometriosis women: a randomized exploratory trial. Gynecol Endocrinol. 2019 Aug;35(8):719-726. https://doi.org/10.1080/09513590.2019.1576612 Epub 2019 Feb 19. PMID: 30777471. Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial. J Minim Invasive Gynecol. 2008 Jan-Feb;15(1):62-6. https://doi.org/10.1016/j.jmig.2007.07.018 PMID: 18262146. Mendes da Silva D, Gross LA, Neto EPG, Lessey BA, Savaris RF. The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial. J Endocr Soc. 2017 Mar 15;1(4):359-369. https://doi.org/10.1210/js.2017-00053 PMID: 29264492; PMCID: PMC5686687. Schwertner A, Conceição Dos Santos CC, Costa GD, Deitos A, de Souza A, de Souza IC, Torres IL, da Cunha Filho JS, Caumo W. Efficacy of melatonin in the treatment of endometriosis: a phase II, randomized, double-blind, placebo-controlled trial. Pain. 2013 Jun;154(6):874-81. https://doi.org/10.1016/j.pain.2013.02.025 Epub 2013 Mar 5. PMID: 23602498. Abokhrais IM, Denison FC, Whitaker LHR, Saunders PTK, Doust A, Williams LJ, Horne AW. A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1). PLoS One. 2020 Jan 17;15(1):e0227695. https://doi.org/10.1371/journal.pone.0227695. Erratum in: PLoS One. 2020 Feb 27;15(2):e0230055. https://doi.org/10.1371/journal.pone.0230055 PMID: 31951599; PMCID: PMC6968860. Rezaeinejad M, Homam H, Gheshlaghi P, Jafari L, Shoari S, Ghaemi M. Synergistic effects of melatonin and dienogest on pain relief in endometriosis: a randomized controlled trial. Obstet Gynecol Sci. 2026 Mar 31. https://doi.org/10.5468/ogs.25053 Epub ahead of print. PMID: 41914017. Shabani F, Hajizadeh K, Hesami M, Shaseb E, Rahmani V, Nasirkandy MP, Mirghafourvand M. Adjunctive vitamin D supplementation in women receiving dienogest therapy for endometriosis: a randomized controlled trial. Sci Rep. 2026 Jul 16. https://doi.org/10.1038/s41598-026-62548-6 Epub ahead of print. PMID: 42463771. Tamura H, Yoshida H, Kikuchi H, Josaki M, Mihara Y, Shirafuta Y, Shinagawa M, Tamura I, Taketani T, Takasaki A, Sugino N. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. J Ovarian Res. 2019 Dec 12;12(1):123. https://doi.org/10.1186/s13048-019-0597-y PMID: 31831028; PMCID: PMC6909621. Mier-Cabrera J, Genera-García M, De la Jara-Díaz J, Perichart-Perera O, Vadillo-Ortega F, Hernández-Guerrero C. Effect of vitamins C and E supplementation on peripheral oxidative stress markers and pregnancy rate in women with endometriosis. Int J Gynaecol Obstet. 2008 Mar;100(3):252-6. https://doi.org/10.1016/j.ijgo.2007.08.018 Epub 2007 Nov 19. PMID: 18005966. Khodarahmian M, Amidi F, Moini A, Kashani L, Salahi E, Danaii-Mehrabad S, Nashtaei MS, Mojtahedi MF, Esfandyari S, Sobhani A. A randomized exploratory trial to assess the effects of resveratrol on VEGF and TNF-α 2 expression in endometriosis women. J Reprod Immunol. 2021 Feb;143:103248. https://doi.org/10.1016/j.jri.2020.103248 Epub 2020 Nov 13. PMID: 33387724. Downloads Published Issue Section License Copyright (c) 2026 Justyna Trzaskalik, Kalina Światlak, Wiktoria Żelazna, Monika Leśniak , Jakub Sokołowski This work is licensed under a Creative Commons Attribution 4.0 International License. All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles. CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (32)

Source provenance

openalex
last seen: 2026-11-21T06:07:56.064915+00:00
License: CC0 · commercial use OK